XLA Life

XLA Life was founded in 2022 by XLA patient and researcher Austin Stack. Our aim is to foster a global community to educate, advocate, and advance research for the rare immune deficiency X-Linked Agammaglobulinemia. We are looking to engage the community - patients and researchers - with the end-goal of improving XLA lives. With recent advancements in technology, XLA has emerged as an ideal candidate for gene therapy. While this is great for the community, we want to ensure the patient is priority in every step of the rapidly developing rare disease landscape.